Matthew Myntti
Founder bij NEXT SCIENCE LIMITED
Vermogen: 2 M $ op 31-03-2024
Profiel
Matthew Myntti is the founder of Next Science Ltd.
which was founded in 2017, where he holds the title of Chief Technology Officer.
He is currently a Director at Microbial Defense System Holdings, Inc. since 2012.
He previously worked at Synthes GmbH as the President-Asia Pacific.
Dr. Myntti received his undergraduate and doctorate degrees from the University of Dayton.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NEXT SCIENCE LTD
3.59% | 14-03-2023 | 10 472 969 ( 3.59% ) | 2 M $ | 31-03-2024 |
Actieve functies van Matthew Myntti
Bedrijven | Functie | Begin |
---|---|---|
NEXT SCIENCE LIMITED | Founder | 20-10-2017 |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Director/Board Member | 30-03-2012 |
Eerdere bekende functies van Matthew Myntti
Bedrijven | Functie | Einde |
---|---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Corporate Officer/Principal | - |
Opleiding van Matthew Myntti
University of Dayton | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NEXT SCIENCE LIMITED | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Health Technology |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Finance |